Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: SkyQuest | PRODUCT CODE: 1701408

Cover Image

PUBLISHER: SkyQuest | PRODUCT CODE: 1701408

In Vitro Fertilization Market Size, Share, and Growth Analysis, By Product Type (Fresh Donor, Fresh Non-Donor), By Product (Equipment, Reagents & Media), By Type, By Instrument, By End User, By Region - Industry Forecast 2025-2032

PUBLISHED:
PAGES: 219 Pages
DELIVERY TIME: 3-5 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 5300
PDF & Excel (Multiple User License)
USD 6200
PDF & Excel (Enterprise License)
USD 7100

Add to Cart

In Vitro Fertilization Market size was valued at USD 26.8 billion in 2023 and is poised to grow from USD 29.05 billion in 2024 to USD 55.39 billion by 2032, growing at a CAGR of 8.4% during the forecast period (2025-2032).

The global In Vitro Fertilization (IVF) market, encompassing assisted reproductive technologies, has gained significant traction as a solution for infertility, enabling couples to conceive through external fertilization processes. With rising infertility rates attributed to lifestyle changes, late pregnancies, and various health conditions, IVF offers hope to those facing challenges in natural conception. Continuous technological advancements, including enhanced laboratory techniques, genetic testing, and improved embryo selection, have boosted success rates, attracting more couples seeking reliable fertility solutions. The demand for IVF is particularly surging in developing regions, where increased awareness and access are driving market growth. Despite the emotional and physical hurdles associated with the treatment, emerging innovations and improving patient experiences present promising opportunities for expansion in the IVF sector.

Top-down and bottom-up approaches were used to estimate and validate the size of the In Vitro Fertilization market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

In Vitro Fertilization Market Segments Analysis

Global In Vitro Fertilization Market is segmented by Product Type, Product, Type, Instrument, End User and region. Based on Product Type, the market is segmented into Fresh Donor, Fresh Non-Donor, Frozen Donor and Frozen Non-Donor. Based on Product, the market is segmented into Equipment, Reagents & Media and Accessories. Based on Type, the market is segmented into Conventional IVF, IVF with ICSI, IVF with Donar Eggs and Others. Based on Instrument, the market is segmented into Culture Media, Disposable Devices and Capital Equipment. Based on End User, the market is segmented into Fertility Clinics, Surgical Centers, Hospitals and Research Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the In Vitro Fertilization Market

The In Vitro Fertilization (IVF) market has experienced considerable growth due to remarkable advancements in reproductive technologies observed in 2021. Notably, the implementation of time-lapse imaging systems revolutionized the monitoring process for embryo development by enabling continuous observation. This innovation facilitated better selection of embryos, ultimately resulting in enhanced success rates for IVF procedures. As a result, these technological improvements have encouraged an increasing number of individuals and couples to pursue IVF treatments, thereby driving the overall demand and expansion of the IVF market in recent years.

Restraints in the In Vitro Fertilization Market

The financial burden of In Vitro Fertilization (IVF) treatments has been a considerable constraint, particularly noted in 2021. The high costs associated with medication, laboratory procedures, and the need for several treatment cycles can be overwhelming. This significant expense often renders IVF unattainable for many individuals and couples, especially those lacking sufficient financial means or insurance coverage. As a result, the affordability of these essential reproductive services remains a major barrier, limiting access for those who might benefit from such treatments and hindering their ability to pursue family planning options effectively.

Market Trends of the In Vitro Fertilization Market

The In Vitro Fertilization (IVF) market is witnessing a notable trend towards the rising demand for genetic testing, particularly techniques like preimplantation genetic testing (PGT). In 2022, the integration of PGT into IVF procedures gained momentum as more couples sought to enhance their chances of successful pregnancies while minimizing the risk of genetic disorders in their future children. This shift is driven by increased awareness of genetic health and advancements in testing technologies, making it a critical factor in reproductive planning. As a result, IVF clinics are increasingly adopting these innovative genetic testing methods, reflecting a broader market trend that favors personalized and health-conscious fertility solutions.

Product Code: SQMIG35H2163

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Analysis
  • Technology Analysis

Global In Vitro Fertilization Market Size by Product Type & CAGR (2025-2032)

  • Market Overview
  • Fresh Donor
  • Fresh Non-Donor
  • Frozen Donor
  • Frozen Non-Donor

Global In Vitro Fertilization Market Size by Product & CAGR (2025-2032)

  • Market Overview
  • Equipment
    • Sperm Analyzer Systems
    • Imaging Systems
    • Ovum Aspiration Pumps
    • Micromanipulator Systems
    • Incubators
    • Gas Analyzers
    • Laser Systems
    • Cryosystems
    • Sperm Separation Devices
    • IVF Cabinets
    • Anti-vibration Tables
    • Witness Systems
    • Other Equipments
  • Reagents & Media
    • Cryopreservation Media
    • Embryo Culture Media
    • Ovum Processing Media
    • Sperm Processing Media
  • Accessories

Global In Vitro Fertilization Market Size by Type & CAGR (2025-2032)

  • Market Overview
  • Conventional IVF
  • IVF with ICSI
  • IVF with Donar Eggs
  • Others

Global In Vitro Fertilization Market Size by Instrument & CAGR (2025-2032)

  • Market Overview
  • Culture Media
  • Disposable Devices
  • Capital Equipment

Global In Vitro Fertilization Market Size by End User & CAGR (2025-2032)

  • Market Overview
  • Fertility Clinics
  • Surgical Centers
  • Hospitals
  • Research Institutes

Global In Vitro Fertilization Market Size & CAGR (2025-2032)

  • North America (Product Type, Product, Type, Instrument, End User)
    • US
    • Canada
  • Europe (Product Type, Product, Type, Instrument, End User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Product Type, Product, Type, Instrument, End User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Product Type, Product, Type, Instrument, End User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Product Type, Product, Type, Instrument, End User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Ferring Pharmaceuticals (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Merck KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cook Medical (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Vitrolife AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CooperSurgical, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ovascience, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Irvine Scientific (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Genea Limited (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Origio A/S (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Thermo Fisher Scientific Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Esco Medical ApS (Denmark)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nidacon International AB (Sweden)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Boston IVF (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Virtus Health (Australia)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Bloom Fertility Centre (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Rainbow IVF (India)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • IVI RMA Global (Spain)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CHA Healthcare (South Korea)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Reproductive Medicine Associates of New Jersey (RMANJ) (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TSLC Corporation (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations

Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!